Chong Lu

Hefei, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

miR-30b-5p suppresses prostate cancer progression by targeting FLVCR1 through the cAMP/PKA/CREB pathway.

miR-30b-5p suppresses prostate cancer progression by targeting FLVCR1 through the cAMP/PKA/CREB pathway.

Journal: Scientific reports
Published: December 01, 2025

A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma.

A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma.

Journal: The International journal of biological markers
Published: April 15, 2025

Serum mature microRNA panel: A novel approach for primary prostate cancer diagnosis.

Serum mature microRNA panel: A novel approach for primary prostate cancer diagnosis.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: November 05, 2024

Panel containing three serum microRNAs: a promising biomarker for early detection of bladder cancer.

Panel containing three serum microRNAs: a promising biomarker for early detection of bladder cancer.

Journal: Frontiers in oncology
Published: July 25, 2024

Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.

Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: May 20, 2024

A panel based on three-miRNAs as diagnostic biomarker for prostate cancer.

A panel based on three-miRNAs as diagnostic biomarker for prostate cancer.

Journal: Frontiers in genetics
Published: January 16, 2024

Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.

Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: November 16, 2023

The value of a three-microRNA panel in serum for prostate cancer screening.

The value of a three-microRNA panel in serum for prostate cancer screening.

Journal: The International journal of biological markers
Published: November 14, 2023

The value of a panel of circulating microRNAs in screening prostate cancer.

The value of a panel of circulating microRNAs in screening prostate cancer.

Journal: Translational cancer research
Published: July 25, 2023

A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma.

A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma.

Journal: Cancer cell international
Published: July 22, 2023

miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.

miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)
Published: June 27, 2023

A serum miRNAs signature for early diagnosis of bladder cancer.

A serum miRNAs signature for early diagnosis of bladder cancer.

Journal: Annals of medicine
Published: March 01, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026